http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020012951-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caec7099b724bb45d2518787825aab94
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56
filingDate 2000-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2129e96fe08c6979329012dbf894ebe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2d663c8114949cdeff77baa6041177b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c36f81caa794324946a137fb41948aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70660422248ed34415aebe0a3f42507f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a30313c140db117f33173fd0e36d303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c80e8d006e6897aa8b568df9824659a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03dde4586c42c00b5e26ea710e166aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f440223652e593ea7fd6b77680c6a61
publicationDate 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20020012951-A
titleOfInvention Cephalosporin derivatives having quaternary hetero compounds and process for preparation thereof
abstract The present invention relates to a cephalosporin derivative, a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition comprising the same. Specifically, the present invention relates to a cepha having a quaternized hetero compound represented by the following Chemical Formula 1. The present invention relates to a rosporin derivative, and the compound of the present invention not only has a strong antibacterial activity, but also has a broad antibacterial spectrum and low toxicity, and thus may be usefully used as an antibiotic.n n n n n n n n n n In Formula 1, R and X are as described in the specification.
priorityDate 2000-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426121837
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544139
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5742673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5479539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415752962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524198
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116

Total number of triples: 45.